Expand ENSC Menu
ENSC MENU

ENSC Latest Press Releases

-- September 24, 2026 --

Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRA ACCESS Newswire 8:00 AM

-- September 15, 2026 --

Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation ACCESS Newswire 9:15 AM

-- September 14, 2026 --

Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs ACCESS Newswire 8:00 AM

-- September 2, 2026 --

Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation ACCESS Newswire 8:31 AM

-- August 31, 2026 --

Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical Study ACCESS Newswire 8:30 AM

-- August 20, 2026 --

Ensysce Biosciences to Showcase "A New Era in Pain Therapeutics" at PAINWeek 2026 Symposium ACCESS Newswire 8:00 AM

-- August 13, 2026 --

Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights ACCESS Newswire 4:15 PM

-- August 6, 2026 --

Why Investors Are Watching These Healthcare Movers Globe Newswire 12:31 PM
Ensysce Biosciences Announces Acquisition of Cy Biopharma and up to $77 Million Private Financing ACCESS Newswire 8:00 AM

-- July 14, 2026 --

Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant ACCESS Newswire 8:00 AM

-- June 26, 2026 --

Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study ACCESS Newswire 8:00 AM

-- May 15, 2026 --

Ensysce Biosciences Reports First Quarter 2026 Financial Results ACCESS Newswire 4:15 PM

-- May 12, 2026 --

Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology ACCESS Newswire 8:00 AM

-- May 8, 2026 --

Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam ACCESS Newswire 8:00 AM
Market Data Delayed 15 Minutes